TGA labelling review
August 6, 2012
THE Therapeutic Goods
Administration has released details
of several submissions to its current
medicine labelling and packaging
review, with the consultation
closing on 24 Aug.
The review, which launched
in May, will cover recommendations
on both OTC and prescription
medicines, including improvements
to the visual presentation of labels
and packages to enable the safe
use of medicines.
One of the submissions, from
UNSW Professor of Clinical
Pharmacology, Ric Day, urges that
generic names on prescription
medicines be much bigger than
brand names, and also be “more
prominent by way of font, bolding
and colour”.
Day also says that to increase the
uptake of generic medicines the
PBS should “purchase generic drugs
only when the patent on the
originator drug expires.”
The above article was sent to subscribers in Pharmacy Daily's issue from 06 Aug 12To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Aug 12